GNH USA

Europe — EMA

Minims (Pilocarpine Nitrate)

GNH USA supplies Minims (Pilocarpine nitrate), a cholinergic agonist miotic agent for open‑angle glaucoma and ocular hypertension. Request a quote for supply.

Request sourcing

1
Pack/s

What is Pilocarpine Nitrate?

Pilocarpine nitrate, the active ingredient in Minims, is a cholinergic agonist (muscarinic agonist) presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with certain types of glaucoma and ocular hypertension. It is indicated for adult patients diagnosed with open‑angle glaucoma or ocular hypertension, where reduction of intra‑ocular pressure is required to prevent optic nerve damage.

GNH USA supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

What is Pilocarpine Nitrate used for?

Pilocarpine nitrate is used as a miotic agent to manage conditions that involve elevated intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to help preserve visual field. Ocular hypertension: lowers pressure to reduce risk of progression to glaucoma.

What are the side effects of Pilocarpine Nitrate?

Pilocarpine nitrate may cause ocular and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Blurred vision - Eye irritation or burning sensation - Increased tearing - Miosis causing difficulty with near vision - Headache - Transient brow ache

Serious or Rare Side Effects: - Severe allergic reaction (angioedema, anaphylaxis) - Persistent miosis leading to acute angle‑closure glaucoma - Corneal ulceration - Systemic cholinergic toxicity (bradycardia, hypotension)

What precautions apply to Pilocarpine Nitrate?

When prescribing Pilocarpine nitrate, clinicians should consider several safety measures.

Assess intra‑ocular pressure before initiating therapy: ensure baseline measurement. Monitor for signs of angle‑closure: discontinue if acute pain or vision loss occurs. Use with caution in patients with asthma or COPD: cholinergic stimulation may exacerbate bronchospasm. Avoid in patients with known hypersensitivity to pilocarpine or other cholinergic agents. Pregnancy and lactation: safety not established; weigh benefits against risks. Store at room temperature: keep in original container, protect from light and moisture.

What does Pilocarpine Nitrate interact with?

Pilocarpine nitrate can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Beta‑blocker eye drops: additive hypotensive effect may cause excessive IOP reduction. - Systemic anticholinergics (e.g., atropine): antagonize pilocarpine effect. - MAO inhibitors: may potentiate cholinergic side effects.

Moderate Interactions (Monitor Closely): - Topical NSAIDs: may increase ocular irritation. - Systemic cholinesterase inhibitors: enhance muscarinic activity. - Other miotics (e.g., carbachol): risk of excessive miosis.

Frequently asked questions

What is Minims used for?+
Minims contains pilocarpine nitrate and is prescribed to lower intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension. By improving aqueous humor outflow, it helps protect the optic nerve and preserve visual function.
How does pilocarpine nitrate work?+
Pilocarpine nitrate is a direct muscarinic (M3) receptor agonist. Activation of these receptors contracts the iris sphincter muscle, producing miosis, and stimulates the trabecular meshwork to increase aqueous humor drainage, thereby reducing intra‑ocular pressure.
What is the usual dose of Minims?+
The dosing regimen for Minims is determined by the prescribing clinician based on the patient’s condition, response, and tolerance. The prescriber will specify the number of drops, frequency, and duration appropriate for each individual case.
Is Minims safe during pregnancy or breastfeeding?+
Safety of pilocarpine nitrate in pregnancy and lactation has not been established. Healthcare providers should evaluate the potential benefits against possible risks before prescribing Minims to pregnant or nursing women.
How do I order Minims from GNH USA?+
To request Minims, submit an enquiry on the product page at gnh-usa.com, indicating the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Minims compare with the main alternative treatment?+
The primary alternative class for lowering intra‑ocular pressure includes prostaglandin analogues such as latanoprost, which increase uveoscleral outflow. Pilocarpine nitrate, a miotic, works by enhancing trabecular outflow and inducing miosis. Choice depends on patient tolerance, target IOP reduction, and clinician preference.
What are the storage and handling requirements for Minims?+
Store Minims at room temperature, preferably below 25 °C, in the original container. Protect the product from direct light and moisture. Do not freeze. Keep the vial tightly closed when not in use.
How is Minims administered?+
Minims is applied as an ocular drop. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place the prescribed number of drops into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few seconds.
What are the most serious risks to watch for while using Minims?+
Serious risks include acute angle‑closure glaucoma triggered by excessive miosis, severe allergic reactions such as angioedema, and systemic cholinergic toxicity manifesting as bradycardia or hypotension. Patients should seek immediate medical attention if they experience sudden eye pain, vision loss, or systemic symptoms.
Who should not use Minims?+
Minims should be avoided in individuals with known hypersensitivity to pilocarpine or other cholinergic agents, in patients with narrow anterior chamber angles at risk for angle‑closure glaucoma, and in those with uncontrolled asthma or severe COPD where cholinergic stimulation could worsen bronchospasm.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Pilocarpine Nitrate
Route
Ocular Use
Manufacturer
Bausch + Lomb Ireland Limited
Origin
EU

Related products